Learn About
VENTUREMED GROUP
Press Releases
2024
2023
2022
- VentureMed announces First patient Enrolled in the FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management (12/15/22) [revised]
- FLEX Vessel Prep 12 Month AV Registry Data and 12 Month Belong PAD Data Shows Benefit to Micro-incisions Before Balloon or DCB Treatment (12/6/22)
- VentureMed FLEX Vessel PrepTM System 12-Month Data To Be Presented at VEITH Symposium 2022 in PAD with DCB’s and AV Access Management (11/14/22)
- VentureMed announces First patient Treated With The FLEX Vessel Prep™ (10/05/22)
- FLEX Vessel Prep AV Registry Data Shows A Longer Lasting Solution to Stand Alone PTA When Treating AV Access Fistulas and Grafts (06/15/22)
- VentureMed Completes Enrollment of FLEX Vessel PrepTM System Randomized Control Trial in Arteriovenous Fistulas
(05/24/22)
2021
2020
2019
2018
VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.
VentureMed Group, Inc. is a member of Medical Alley
VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.
VentureMed Group, Inc. is a member of Medical Alley